Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. - Current Ratio

The Current Ratio as of August 2026 (TTM) for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) is 7.46

According to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 7.46. This represents a change of 2.37% compared to the average of 7.29 of the last 4 quarters.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) Historical Current Ratio (quarterly & annually)

How has 1349.HK Current Ratio performed in the past?

The mean historical Current Ratio of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. over the last ten years is 3.79. The current 7.46 Current Ratio has changed 19.60% with respect to the historical average. Over the past ten years (40 quarters), 1349.HK's Current Ratio was at its highest in in the September 2025 quarter at 8.68. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) Average Current Ratio

How has 1349.HK Current Ratio performed in the past?

The current Current Ratio of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) Current Ratio vs. Peers

How is 1349.HK’s Current Ratio compared to its peers?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s Current Ratio is greater than Lee's Pharmaceutical Holdings Limited (1.03), greater than Jilin Province Huinan Changlong Bio-pharmacy Company Limited (1.30), less than Sunho Biologics, Inc. (11.17), greater than Venus Medtech (Hangzhou) Inc. (2.77), greater than Arrail Group Limited (1.92), greater than Tian An Medicare Limited (2.15), greater than EuroEyes International Eye Clinic Limited (2.79), greater than Transcenta Holding Limited (0.25), greater than Sirnaomics Ltd. (0.40), less than Pak Fah Yeow International Limited (18.40),

Build a custom stock screener for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.